$CRNT

Makov Efrat sold $15K of CRNT

Makov Efrat sold 5,000 shares of CERAGON NETWORKS LTD (CRNT) at $2.99 on 2026-06-12.

Original reporting
SEC EDGAR · Makov Efrat
Published Jun 15, 2026, 10:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 10:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CRNT
Neutral
high confidence
Mentioned
$CRNT
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRNTNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale of 5,000 shares at $2.9943/share, totaling $14,971.50, with post-transaction holdings of 58,950 shares.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a major repricing without accompanying fundamentals.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says 'No'), but it also provides no context on compensation, tax obligations, or prior sale patterns.

Relevance 3/10Novelty 6/10Timing: Filed on 2026-06-15 for a sale dated 2026-06-12

Background

The article is an SEC Form 4 insider transaction disclosure for Ceragon Networks Ltd (CRNT).

Company-level read

Ticker impact

$CRNTNeutralHigh confidence
Context

SEC Form 4 shows director Makov Efrat sold 5,000 CRNT shares in an open-market transaction on 2026-06-12.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is a disclosed sale by a director with no 10b5-1 plan stated, but the article provides no new company-specific operational or financial information.

Market effects

No sector-level read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity or diversification; without evidence of distress, the signal may be overstated.

Key entities

  • Ceragon Networks Ltd

    Subject of the Form 4 insider transaction disclosure (CRNT).

  • Makov Efrat

    Director who sold 5,000 shares of CRNT on 2026-06-12.

Related articles

$CRNTLow

Craig - Hallum Raises its Price Target on Ceragon Networks (CRNT)

On May 20, 2026, Craig-Hallum analyst Christian Schwab raised Ceragon Networks’ (CRNT) price target to $4 from $3 and kept a Buy rating, citing solid Q1 results and full-year revenue guidance of $355M–$385M. Roth Capital analyst Scott Searle raised its target to $4.50 from $3.75, also maintaining Buy. Ceragon reported Q1 non-GAAP EPS of 1c and revenue of $85.0M, above consensus, while noting margin pressure from costs and FX.

$CRNTMedAI 9/10

Ceragon Networks (CRNT) Is Banking on India to Make Up for a Slow Start to 2026

Ceragon Networks (NASDAQ:CRNT) reported Q1 2026 revenue of $85.0 million, down 4.1% year over year but above Wall Street’s $80.4 million consensus, according to the company. CEO Doron Arazi attributed the decline to timing of Indian operator orders converting to revenue. India accounted for 35% of revenue; management said it booked about $86 million in orders year-to-date, with ~$24 million recognized in Q1. Non-GAAP EPS was $0.01 vs $0.03 in Q1 2025; GAAP gross margin rose to 35.4%. CFO Ronen S